Detalles de la búsqueda
1.
Exemestane for breast-cancer prevention in postmenopausal women.
N Engl J Med
; 364(25): 2381-91, 2011 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21639806
2.
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.
Breast Cancer Res Treat
; 138(1): 249-59, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23378108
3.
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Cancer
; 118(1): 241-7, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717449
4.
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Breast
; 54: 286-292, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33242755
5.
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
J Clin Oncol
; 32(14): 1427-36, 2014 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711552
6.
National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women.
Clin Breast Cancer
; 7(11): 895-900, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18269782
Resultados
1 -
6
de 6
1
Próxima >
>>